出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年2月
製品（吸引針、CNB、VAB）、用途（乳房、肺、骨肉腫）、手順（画像誘導（超音波、MRI、定位）、非画像誘導）、エン吸引および生検針市場：ドユーザー（病院、ASC、アカデミア）- 2027年までの世界予測
Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End user (Hospital, ASC, Academia) – Global Forecasts to 2027
| ページ数 | 198 |
| 図表数 | 173 |
| 種別 | 英文調査報告書 |
| 価格 |
The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures.
“The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.”
On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer.
“The Hospitals segment is expected to witness the highest growth during the forecast period.”
On the basis of end user, the aspiration and biopsy needles market is segmented into hospitals & surgical centers, ambulatory care centers, diagnostic clinics & pathology laboratories, and research & academic institutes. The hospitals & surgical centers segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.
“On the basis of application, the breast cancer segment is expected to hold the largest share of the market in 2021.”
On the basis of application, the aspiration and biopsy needles market is segmented by tumor/cancer applications (breast, lung, colorectal, prostate, kidney, bone & bone marrow, and other cancers), wound applications, and other applications. The breast cancer segment accounted for the largest share of the aspiration and biopsy needles market in 2020. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis
“Image-guided procedure segment is expected to witness the highest growth during the forecast period.”
On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and nonimage-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.
“Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period.”
Emerging economies such as India, China, and South Korea are offering high-growth opportunities for market players. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 48%, Tier 2 – 36%, and Tier 3 – 16%
• By Designation: C-level – 10%, Director-level – 14%, and Others – 76%
• By Region: North America – 40%, Europe – 32%, APAC – 20%, and RoW – 8%
The major players operating in the global aspiration and biopsy needles market are
CONMED Corporation (US), Stryker Corporation (US), Medtronic plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices (US), INRAD Inc. (US), Somatex Medical Technologies GmbH (Germany), Cardinal Health (US), Remington Medical (US), Hakko Co., Ltd. (Japan), Merit Medical Systems (US), and Ranfac Corporation (US), among others.
Research Coverage
This report studies the aspiration and biopsy needles market by product, application, procedure, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the aspiration and biopsy needles market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the aspiration and biopsy needles market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the aspiration and biopsy needles market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目次
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 27
1.3 MARKETS COVERED 27
FIGURE 1 ASPIRATION AND BIOPSY NEEDLES MARKET SEGMENTATION 27
1.4 YEARS CONSIDERED FOR THE STUDY 28
1.5 CURRENCY 28
TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.2 RESEARCH DESIGN 31
FIGURE 2 ASPIRATION AND BIOPSY NEEDLES MARKET: RESEARCH DESIGN 31
2.2.1 SECONDARY RESEARCH 32
2.2.1.1 Secondary sources 33
2.2.2 PRIMARY DATA 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.3 MARKET ESTIMATION METHODOLOGY 34
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35
2.3.1 TOP-DOWN AND BOTTOM-UP APPROACHES FOR MARKET ESTIMATION 35
2.3.2 REVENUE MAPPING-BASED MARKET ESTIMATION 36
FIGURE 5 ASPIRATION AND BIOPSY NEEDLES MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION APPROACH 37
FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET: TOP-DOWN APPROACH 37
2.3.3 PRIMARY RESEARCH VALIDATION 37
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY 38
2.5 RESEARCH ASSUMPTIONS 39
2.6 RESEARCH LIMITATIONS 39
3 EXECUTIVE SUMMARY 40
FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2021 VS. 2027 (USD MILLION) 40
FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,
2021 VS. 2027 (USD MILLION) 41
FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,
2021 VS. 2027 (USD MILLION) 42
FIGURE 11 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY END USER,
2021 VS. 2027 43
FIGURE 12 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 44
4 PREMIUM INSIGHTS 45
4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW 45
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE IS DRIVING MARKET GROWTH 45
4.2 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2021 VS. 2027 (USD MILLION) 46
FIGURE 14 BIOPSY NEEDLES SEGMENT TO HOLD MAJOR SHARE OF THE NORTH AMERICAN MARKET 46
4.3 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,
2021 VS. 2027 (USD MILLION) 46
FIGURE 15 ULTRASOUND-GUIDED PROCEDURES SEGMENT TO DOMINATE
THE ASIA PACIFIC MARKET 46
4.4 MEA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,
2021 VS. 2027 (USD MILLION) 47
FIGURE 16 BREAST CANCER APPLICATIONS SEGMENT TO DOMINATE THE MEA MARKET 47
4.5 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,
2021 VS. 2027 (USD MILLION) 48
FIGURE 17 HOSPITALS & SURGICAL CENTERS FORMED THE LARGEST END-USER SEGMENT IN THE EUROPEAN MARKET 48
4.6 GEOGRAPHIC SNAPSHOT OF THE ASPIRATION AND BIOPSY NEEDLES MARKET 49
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 MARKET DYNAMICS 50
FIGURE 19 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.1.1 DRIVERS 51
5.1.1.1 Rising prevalence of cancer 51
FIGURE 20 NUMBER OF NEW CANCER CASES (GLOBAL), 2018 VS. 2020 51
5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations 52
5.1.1.3 Increasing preference for minimally invasive biopsies 53
5.1.2 RESTRAINTS 53
5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles 53
5.1.2.2 Product recalls 54
TABLE 2 RECENT PRODUCT RECALLS BY FDA 54
5.1.3 OPPORTUNITIES 54
5.1.3.1 Emerging economies 54
5.1.4 CHALLENGES 55
5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists 55
5.2 INDUSTRY TRENDS 55
5.2.1 EMERGENCE OF LIQUID BIOPSY 55
5.3 VALUE CHAIN ANALYSIS 56
FIGURE 21 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING
THE MANUFACTURING PHASE 56
5.4 REGULATORY ANALYSIS 57
5.4.1 NORTH AMERICA 57
5.4.1.1 US 57
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION 57
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
5.4.1.2 Canada 58
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 59
5.4.2 EUROPE 59
FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 60
5.4.3 ASIA PACIFIC 61
5.4.3.1 Japan 61
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61
5.4.3.2 China 62
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62
5.4.3.3 India 63
5.5 PORTER’S FIVE FORCES ANALYSIS 64
TABLE 8 ASPIRATION AND BIOPSY NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.5.1 THREAT OF NEW ENTRANTS 64
5.5.2 THREAT OF SUBSTITUTES 64
5.5.3 BARGAINING POWER OF SUPPLIERS 64
5.5.4 BARGAINING POWER OF BUYERS 64
5.5.5 DEGREE OF COMPETITION 65
5.6 IMPACT OF COVID-19 ON THE ASPIRATION AND BIOPSY NEEDLES MARKET 65
5.7 ECOSYSTEM COVERAGE: ASPIRATION AND BIOPSY NEEDLES MARKET 66
5.8 TRADE ANALYSIS 66
5.8.1 TRADE ANALYSIS FOR BIOPSY NEEDLES 67
TABLE 9 EXPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY,
2018–2020 (USD MILLION) 67
TABLE 10 IMPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY,
2018–2020 (USD MILLION) 67
5.9 TECHNOLOGY ANALYSIS 68
5.10 PATENT ANALYSIS 68
FIGURE 24 TOP 10 PATENT APPLICANTS FOR ASPIRATION AND BIOPSY NEEDLES (DECEMBER 2021) 68
FIGURE 25 PATENT APPLICATIONS FOR ASPIRATION AND BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021) 69
FIGURE 26 TOP 10 PATENT APPLICANTS FOR BIOPSY NEEDLES
(JANUARY 2011 TO DECEMBER 2021) 69
FIGURE 27 PATENT APPLICATIONS FOR ASPIRATION NEEDLES
(JANUARY 2011 TO DECEMBER 2021) 70
6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 71
6.1 INTRODUCTION 72
TABLE 11 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 72
6.2 BIOPSY NEEDLES 72
TABLE 12 BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 73
TABLE 13 BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 73
6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE,
2019–2027 (USD MILLION) 74
TABLE 14 BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 74
6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,
2019–2027 (USD MILLION) 74
TABLE 15 BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 74
6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION) 75
TABLE 16 BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 75
6.2.4 CORE BIOPSY NEEDLES 75
6.2.4.1 Core biopsy needles are widely used for sample collection in most prevalent cancer types 75
TABLE 17 CORE BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 76
6.2.5 CORE BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE,
2019–2027 (USD MILLION) 76
TABLE 18 CORE BIOPSY NEEDLES MARKET, BY PROCEDURE,
2019–2027 (USD MILLION) 76
6.2.6 CORE BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,
2019–2027 (USD MILLION) 77
TABLE 19 CORE BIOPSY NEEDLES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 77
6.2.7 CORE BIOPSY NEEDLES MARKET SPLIT, BY END USER,
2019–2027 (USD MILLION) 77
TABLE 20 CORE BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 77
6.2.8 VACUUM-ASSISTED BIOPSY NEEDLES 78
6.2.8.1 High-volume sampling and greater specificity of VAB procedures to drive the growth of this market segment 78
TABLE 21 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION,
2019–2027 (USD MILLION) 78
6.2.9 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION) 79
TABLE 22 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY PROCEDURE,
2019–2027 (USD MILLION) 79
6.2.10 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION) 79
TABLE 23 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 79
6.2.11 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY END USER,
2019–2027 (USD MILLION) 80
TABLE 24 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY END USER,
2019–2027 (USD MILLION) 80
6.3 ASPIRATION NEEDLES 80
6.3.1 ASPIRATION NEEDLES ARE ESTIMATED TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET 80
TABLE 25 ASPIRATION NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 81
6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE,
2019–2027 (USD MILLION) 81
TABLE 26 ASPIRATION NEEDLES MARKET, BY PROCEDURE,
2019–2027 (USD MILLION) 81
6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY APPLICATION,
2019–2027 (USD MILLION) 82
TABLE 27 ASPIRATION NEEDLES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 82
6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER,
2019–2027 (USD MILLION) 82
TABLE 28 ASPIRATION NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 82
7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 83
7.1 INTRODUCTION 84
TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,
2019–2027 (USD MILLION) 84
7.2 IMAGE-GUIDED PROCEDURES 84
TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2019–2027 (USD MILLION) 85
7.2.1 ULTRASOUND-GUIDED PROCEDURES 85
7.2.1.1 Ultrasound imaging is the preferred imaging standard for most common cancer types 85
TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 86
7.2.2 STEREOTACTIC PROCEDURES 86
7.2.2.1 Stereotactic procedures are still considered the global standard in biopsies 86
TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 87
7.2.3 CT-GUIDED PROCEDURES 87
7.2.3.1 CT imaging is the preferred imaging standard for lung and liver cancers 87
TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR CT-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 88
7.2.4 MRI-GUIDED PROCEDURES 88
7.2.4.1 MRI imaging is the preferred imaging standard for several common cancer types 88
TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 89
7.2.5 OTHER IMAGE-GUIDED PROCEDURES 89
TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 90
7.3 NON-IMAGE-GUIDED PROCEDURES 90
7.3.1 NON-IMAGE-GUIDED PROCEDURES SEGMENT TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET 90
TABLE 36 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NON-IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 91
8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION 92
8.1 INTRODUCTION 93
TABLE 37 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,
2019–2027 (USD MILLION) 93
8.2 TUMOR/CANCER APPLICATIONS 93
TABLE 38 ASPIRATION AND BIOPSY NEEDLES MARKET FOR TUMOR/CANCER APPLICATIONS, BY TYPE, 2019–2027 (USD MILLION) 94
8.2.1 BREAST CANCER 94
8.2.1.1 Increasing awareness of breast cancer to drive the growth of this market segment 94
TABLE 39 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST CANCER,
BY REGION, 2019–2027 (USD MILLION) 95
8.2.2 LUNG CANCER 95
8.2.2.1 Growing prevalence of lung cancer to support the growth of this market segment 95
TABLE 40 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG CANCER, BY REGION, 2019–2027 (USD MILLION) 96
8.2.3 COLORECTAL CANCER 96
8.2.3.1 Advancements in alternative diagnosis techniques to reduce
the adoption of colorectal biopsy needles 96
TABLE 41 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL CANCER,
BY REGION, 2019–2027 (USD MILLION) 97
8.2.4 PROSTATE CANCER 97
8.2.4.1 Availability of funds for prostate cancer research by different government authorities to support the growth of this market segment 97
TABLE 42 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE CANCER,
BY REGION, 2019–2027 (USD MILLION) 98
8.2.5 KIDNEY CANCER 98
8.2.5.1 Rising prevalence of kidney cancer to support the growth of this market segment 98
TABLE 43 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY CANCER,
BY REGION, 2019–2027 (USD MILLION) 99
8.2.6 BONE & BONE MARROW CANCER 99
8.2.6.1 Rising incidence of bone cancer to fuel the growth of this market segment 99
TABLE 44 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE & BONE MARROW CANCER, BY REGION, 2019–2027 (USD MILLION) 100
8.2.7 OTHER CANCERS 100
TABLE 45 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER CANCERS,
BY REGION, 2019–2027 (USD MILLION) 101
8.3 WOUND APPLICATIONS 101
8.3.1 THE DEMAND FOR WOUND BIOPSIES IS EXPECTED TO INCREASE WITH
THE INCREASE IN PREVALENCE OF DIABETIC FOOT ULCERS 101
TABLE 46 ASPIRATION AND BIOPSY NEEDLES MARKET FOR WOUND APPLICATIONS,
BY REGION, 2019–2027 (USD MILLION) 102
8.4 OTHER APPLICATIONS 102
TABLE 47 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2019–2027 (USD MILLION) 102
9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 103
9.1 INTRODUCTION 104
TABLE 48 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,
2019–2027 (USD MILLION) 104
9.2 HOSPITALS & SURGICAL CENTERS 104
9.2.1 HOSPITALS AND SURGICAL CENTERS ARE THE LARGEST END USERS OF ASPIRATION AND BIOPSY NEEDLES 104
TABLE 49 ASPIRATION AND BIOPSY NEEDLES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2027 (USD MILLION) 105
9.3 AMBULATORY CARE CENTERS 105
9.3.1 PREFERENCE FOR NEEDLE BIOPSIES IN AMBULATORY CARE CENTERS IS INCREASING DUE TO ONE-DAY OUTPATIENT SURGERY TIMELINES 105
TABLE 50 ASPIRATION AND BIOPSY NEEDLES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2027 (USD MILLION) 106
9.4 DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES 106
9.4.1 A MAJORITY OF SAMPLE DIAGNOSIS IS PERFORMED BY DIAGNOSTIC/PATHOLOGY LABORATORIES 106
TABLE 51 ASPIRATION AND BIOPSY NEEDLES MARKET FOR DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES, BY REGION, 2019–2027 (USD MILLION) 107
9.5 RESEARCH & ACADEMIC INSTITUTES 107
9.5.1 MARKET FOR BIOPSY NEEDLES IN RESEARCH & ACADEMIC INSTITUTES IS EXPECTED TO GROW WITH GROWTH IN CANCER RESEARCH 107
TABLE 52 ASPIRATION AND BIOPSY NEEDLES MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2027 (USD MILLION) 108
10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 109
10.1 INTRODUCTION 110
TABLE 53 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION,
2019–2027 (USD MILLION) 110
10.2 ASIA PACIFIC 110
FIGURE 28 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 111
TABLE 54 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 112
TABLE 55 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 112
TABLE 56 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 113
TABLE 57 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 113
TABLE 58 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 114
TABLE 59 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 114
10.2.1 CHINA 115
10.2.1.1 China is the largest market for aspiration and biopsy needles in APAC 115
TABLE 60 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 115
TABLE 61 CHINA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 115
10.2.2 JAPAN 116
10.2.2.1 Japan is the second-largest market for aspiration and biopsy needles in APAC 116
TABLE 62 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 116
TABLE 63 JAPAN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 117
10.2.3 INDIA 117
10.2.3.1 Improving healthcare infrastructure to drive market growth in India 117
TABLE 64 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 118
TABLE 65 INDIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 118
10.2.4 SOUTH KOREA 119
10.2.4.1 Growing healthcare expenditure to drive market growth in
South Korea 119
TABLE 66 SOUTH KOREA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 119
TABLE 67 SOUTH KOREA: BIOPSY NEEDLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 119
10.2.5 AUSTRALIA 120
10.2.5.1 Increasing prevalence of cancer to drive market growth in Australia 120
TABLE 68 AUSTRALIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 120
TABLE 69 AUSTRALIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 120
10.2.6 REST OF ASIA PACIFIC 121
TABLE 70 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 121
TABLE 71 ROAPAC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 121
10.3 EUROPE 122
TABLE 72 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY,
2019–2027 (USD MILLION) 122
TABLE 73 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 122
TABLE 74 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 123
TABLE 75 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 123
TABLE 76 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 124
TABLE 77 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,
2019–2027 (USD MILLION) 124
10.3.1 GERMANY 125
10.3.1.1 Higher per capita spending on healthcare and presence of notable players to drive market growth in Germany 125
TABLE 78 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 125
TABLE 79 GERMANY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 125
10.3.2 FRANCE 126
10.3.2.1 Increasing prevalence of cancer to drive market growth in France 126
TABLE 80 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 126
TABLE 81 FRANCE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 126
10.3.3 UK 127
10.3.3.1 Higher per capita spending on healthcare and the presence of notable players are expected to support market growth in the UK 127
TABLE 82 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 127
TABLE 83 UK: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 127
10.3.4 ITALY 128
10.3.4.1 Increasing geriatric population to drive market growth in Italy 128
TABLE 84 ITALY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 128
TABLE 85 ITALY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 128
10.3.5 SPAIN 129
10.3.5.1 Growing prevalence of cancer to drive market growth in Spain 129
TABLE 86 SPAIN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 129
TABLE 87 SPAIN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 129
10.3.6 REST OF EUROPE 130
TABLE 88 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 130
TABLE 89 ROE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 130
10.4 NORTH AMERICA 131
FIGURE 29 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 131
TABLE 90 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 132
TABLE 91 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 132
TABLE 92 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 132
TABLE 93 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY APPLICATION, 2019–2027 (USD MILLION) 133
TABLE 94 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY PROCEDURE, 2019–2027 (USD MILLION) 133
TABLE 95 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY END USER, 2019–2027 (USD MILLION) 134
10.4.1 US 134
10.4.1.1 The US dominates the North American aspiration and biopsy needles market 134
TABLE 96 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 135
TABLE 97 US: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 135
10.4.2 CANADA 135
10.4.2.1 Growing incidence of cancer to drive market growth in Canada 135
TABLE 98 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 136
TABLE 99 CANADA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 136
10.5 LATIN AMERICA 137
TABLE 100 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137
TABLE 101 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 137
TABLE 102 LATIN AMERICA: BIOPSY NEEDLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 138
TABLE 103 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY APPLICATION, 2019–2027 (USD MILLION) 138
TABLE 104 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY PROCEDURE, 2019–2027 (USD MILLION) 139
TABLE 105 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 139
10.5.1 BRAZIL 140
10.5.1.1 Brazil is the largest market for aspiration and biopsy needles
in LATAM 140
TABLE 106 BRAZIL: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 140
TABLE 107 BRAZIL: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 140
10.5.2 MEXICO 141
10.5.2.1 Increasing healthcare spending to drive market growth in Mexico 141
TABLE 108 MEXICO: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 141
TABLE 109 MEXICO: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 141
10.5.3 REST OF LATIN AMERICA 142
TABLE 110 ROLA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,
2019–2027 (USD MILLION) 142
TABLE 111 ROLA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 142
10.6 MIDDLE EAST & AFRICA 143
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN MEA 143
TABLE 112 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY PRODUCT, 2019–2027 (USD MILLION) 143
TABLE 113 MIDDLE EAST & AFRICA: BIOPSY NEEDLES MARKET, BY TYPE,
2019–2027 (USD MILLION) 143
TABLE 114 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY APPLICATION, 2019–2027 (USD MILLION) 144
TABLE 115 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY PROCEDURE, 2019–2027 (USD MILLION) 144
TABLE 116 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY END USER, 2019–2027 (USD MILLION) 145
11 COMPETITIVE LANDSCAPE 146
11.1 OVERVIEW 146
11.2 KEY PLAYER STRATEGIES 146
11.3 MARKET SHARE ANALYSIS: ASPIRATION AND BIOPSY NEEDLES MARKET,
BY KEY PLAYER (2020) 146
FIGURE 30 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN
THE ASPIRATION AND BIOPSY NEEDLES MARKET IN 2020 147
11.4 COMPANY EVALUATION QUADRANT FOR 25 MAJOR PLAYERS (2020) 148
11.4.1 STARS 148
11.4.2 EMERGING LEADERS 148
11.4.3 PERVASIVE PLAYERS 148
11.4.4 PARTICIPANTS 148
FIGURE 31 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 149
11.5 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020) 150
11.5.1 PROGRESSIVE COMPANIES 150
11.5.2 RESPONSIVE COMPANIES 150
11.5.3 DYNAMIC COMPANIES 150
11.5.4 STARTING BLOCKS 150
FIGURE 32 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020) 151
11.6 COMPETITIVE BENCHMARKING 152
TABLE 117 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET 152
TABLE 118 REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET 153
11.7 COMPETITIVE SCENARIO (2018–2021) 154
11.7.1 NEW PRODUCT LAUNCHES AND APPROVALS 154
11.7.2 DEALS 154
12 COMPANY PROFILES 155
12.1 INTRODUCTION 155
12.2 KEY PLAYERS 155
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.2.1 BECTON, DICKINSON AND COMPANY (BD) 155
TABLE 119 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 155
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 156
12.2.2 MERIT MEDICAL SYSTEMS 159
TABLE 120 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 159
FIGURE 34 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020) 160
12.2.3 COOK GROUP INCORPORATED 162
TABLE 121 COOK GROUP INCORPORATED: BUSINESS OVERVIEW 162
12.2.4 OLYMPUS CORPORATION 166
TABLE 122 OLYMPUS CORPORATION: BUSINESS OVERVIEW 166
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 167
12.2.5 MEDTRONIC, PLC 169
TABLE 123 MEDTRONIC, PLC: BUSINESS OVERVIEW 169
FIGURE 36 MEDTRONIC, PLC: COMPANY SNAPSHOT (2020) 170
12.2.6 ARGON MEDICAL DEVICES, INC. 172
TABLE 124 ARGON MEDICAL DEVICES, INC: BUSINESS OVERVIEW 172
12.2.7 BOSTON SCIENTIFIC CORPORATION 174
TABLE 125 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 174
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 175
12.2.8 CARDINAL HEALTH, INC. 177
TABLE 126 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 177
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021) 178
12.2.9 CONMED CORPORATION 179
TABLE 127 CONMED CORPORATION: BUSINESS OVERVIEW 179
FIGURE 39 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 180
12.2.10 HAKKO CO., LTD. 182
TABLE 128 HAKKO CO., LTD.: BUSINESS OVERVIEW 182
12.2.11 INRAD INC. 183
TABLE 129 INRAD INC.: BUSINESS OVERVIEW 183
12.2.12 RANFAC CORPORATION 185
TABLE 130 RANFAC CORPORATION: BUSINESS OVERVIEW 185
12.2.13 REMINGTON MEDICAL INC. 186
TABLE 131 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW 186
12.2.14 SOMATEX MEDICAL TECHNOLOGIES 188
TABLE 132 SOMATEX MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 188
12.2.15 STRYKER CORPORATION 189
TABLE 133 STRYKER CORPORATION: BUSINESS OVERVIEW 189
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 190
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.3 OTHER PLAYERS 191
12.3.1 CREGANNA 191
12.3.2 STERYLAB SRL 191
12.3.3 DR. JAPAN CO., LTD. 192
12.3.4 DTR MEDICAL 192
12.3.5 ISCON SURGICALS LTD. 193
12.3.6 JOHNSON & JOHNSON MEDICAL DEVICES 193
12.3.7 SHANGHAI SA MEDICAL & PLASTIC INSTRUMENTS 194
12.3.8 MEDAX MEDICAL DEVICES 195
12.3.9 MEDITECH DEVICES 195
12.3.10 WELLGO MEDICAL PRODUCTS GMBH 196
13 APPENDIX 197
13.1 DISCUSSION GUIDE 197
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 200
13.3 AVAILABLE CUSTOMIZATIONS 202
13.4 RELATED REPORTS 202
13.5 AUTHOR DETAILS 203